College statement on NICE guideline on Cannabis-based medicinal products

The National Institute for Health and Care Excellence (NICE) has published its guideline on Cannabis-based medicinal products.

College statement on NICE guideline on Cannabis-based medicinal products

The National Institute for Health and Care Excellence (NICE) has published its guideline [on Cannabis-based medicinal products.

In September 2019, our College responded to a consultation on this, with contributions and comments made by our Honorary Secretary and members of the College. Consultation responses help to shape the guidelines that NICE provides.

While we supported the use of specific indications for some cannabis derivatives which are supported by evidence such as some childhood epilepsy (which was outside the scope of this review), intractable nausea and vomiting and spasticity, we agreed that without trial evidence, other indications could not be recommended. We were also concerned that the public may obtain cannabis from non-pharmacy sources on the basis of a therapeutic indication and therefore the content and purity of the compounds may be undetermined and potentially harmful.

You can read the full response we submitted to NICE on our website.  


Back to all articles


We provide a daily update on the day’s top health news by WhatsApp. To subscribe, please add our number (+447458012663) to your contacts as “College Voice” and then send "NEWS" as a WhatsApp message to +447458012663 for a daily update for the news that matters to you.

Who we are

We are a worldwide community of inspiring health professionals working together to advance our profession and improve patient care.

Read more

What we do

Over the past year we’ve made great advances in professionalising our approach to engaging more effectively with government and the wider health sector.

Read more

What we stand for

Together we are demanding action to address workforce shortages and implement solutions to help reduce staff burnout.

Read more